CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 11,473	$ 9,758
General and administrative	6,195	4,635
Total operating expenses	17,668	14,393
Loss from operations	(17,668)	(14,393)
Other income (expense), net:
Interest income	1,446	1,807
Other expense, net	(264)	(170)
Total other income, net	1,182	1,637
Net loss	$ (16,486)	$ (12,756)
Net loss per share—basic	$ (0.73)	$ (0.58)
Net loss per share—diluted	$ (0.73)	$ (0.58)
Weighted-average common stock outstanding—basic	22,590,804	21,920,570
Weighted-average common stock outstanding—diluted	22,590,804	21,920,570
Comprehensive loss:
Net loss	$ (16,486)	$ (12,756)
Other comprehensive income:
Unrealized gain on available-for-sale investments, net of tax	13	104
Comprehensive loss	$ (16,473)	$ (12,652)